Fully diluted it stands at approx. 1/8th of the MC of RAP. If RAP attain FDA approval I would expect MNQ to follow suit. As a long term holder this ann has certainly come out of the blue.
Ann: MNQ to acquire ground-breaking pain management app developer-MNQ.AX, page-34
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
